Bellevue Funds (Lux) - Bellevue Asia Pacific Healthcare I CHF Acc Fonds
|
WKN DE: A2DPA4 / ISIN: LU1587984920
Anlageziel
The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of the Asia-Pacific region. The universe for companies is determined cumulatively as follows: Shares of companies that have their registered office or carry out the majority of their economic activity in the healthcare sector in the Asia-Pacific region. These include companies operating in such areas as generics, medtech, biotech, pharma and health services which are involved in the development, manufacture or sale of products and services. Listed on a recognised stock market or, in the case of an initial public offering, the company has applied for listing on the relevant exchange.
Stammdaten
WKN | A2DPA4 |
ISIN | LU1587984920 |
Fondsgesellschaft | Bellevue Asset Management |
Kategorie | Branchen: Gesundheitswesen |
Währung | CHF |
Mindestanlage | 0,00 |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager | Oliver Kubli, Remo Krauer |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 139,02 |
Fondsvolumen | 123 052 294,63 |
Total Expense Ratio (TER) | 1,48 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | 0,00 % |
Ausgabeaufschlag | 5,00 % |
Basisdaten
Auflagedatum | 28.04.2017 |
Depotbank | CACEIS Investor Services Bank S.A. |
Zahlstelle | DZ PRIVATBANK SA |
Domizil | Luxembourg |
Geschäftsjahr | 30.06.2024 |
Performancedaten
Veränderung Vortag | 1,34 |